Unique ID issued by UMIN | UMIN000021915 |
---|---|
Receipt number | R000024422 |
Scientific Title | A Randomized, Single-center, Parallel-group, Prospective Trial of Neuroprotective Effect of Liraglutide for Treatment of Diabetic Polyneuropathy. |
Date of disclosure of the study information | 2016/04/16 |
Last modified on | 2021/02/03 10:09:13 |
A Randomized, Single-center, Parallel-group, Prospective Trial of Neuroprotective Effect of Liraglutide for Treatment of Diabetic Polyneuropathy.
Treatment of Diabetic Poluneuropathy With Liraglutide
A Randomized, Single-center, Parallel-group, Prospective Trial of Neuroprotective Effect of Liraglutide for Treatment of Diabetic Polyneuropathy.
Treatment of Diabetic Poluneuropathy With Liraglutide
Japan |
Diabetic Polyneuropathy
Medicine in general | Endocrinology and Metabolism | Neurology |
Adult |
Others
NO
To investigate effectiveness of treatment with liraglutide in patients with diabetic polyneuropathy
Efficacy
Confirmatory
Pragmatic
Not applicable
1. Change from screening in corneal confocal microscopic findings at month 36
2. Change from screening in nerve conduction studies at month 36
1. Score of Michigan Neuropathy Screening Instrument(MNSI)
2. Clinical findings: i) Absent or hypoactive Achilles tendon reflexes, ii) Impaired vibration sensation
3. HbA1c, blood glucose
4. Coefficients of variance of RR intervals
5. Diabetic nephropathy, Diabetic retinopathy
6. Laboratory data, blood pressure
7. Current perception threshold, Electronic pupillometer, Electroretinography
8. Mini Mental State Examination(MMSE)
9. Safety
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
Liraglutide, 0.9 mg/day, 2 years
Control
20 | years-old | <= |
75 | years-old | > |
Male and Female
Correspond to all of the following in recruitment of participants with type 2 diabetes:
1. HbA1c: 7.0%<, <=13.0%
2. Diabetes treatment including diet therapy, exercise therapy, medication, and insulin therapy
3. Patients who meets more than 2 of 3 below:
i) Bilateral neuropathic symptom of lower extremities
ii) Bilateral decreased vibration sensation of lower extremities
iii) Bilateral decrease or absence of Achilles tendon reflexes.
1. Pregnancy, lactation
2. Allergic to Liraglutide
3. Past usage of GLP-1 receptor agonists or DPP4 inhibitors
4. Type 1 diabetes, othertypes of diabetes
5. Past history of diabetic ketoacidosis
6. Severe infection, Pre-/post-operation, Severe injuries
7. Treatment with steroids
8. Current/Past malignancy
9. Inappropriate patients for entry on this study in the judgement of the investigator
60
1st name | Jiro |
Middle name | |
Last name | Nakamura |
Aichi Medical University
Diabetes
480-1195
1-1 Yazakokarimata, Nagakute, Aichi
0561-63-1683
jiro@aichi-med-u.ac.jp
1st name | Tatsuhito |
Middle name | |
Last name | Himeno |
Aichi Medical University
Diabetes
480-1195
1-1 Yazakokarimata, Nagakute, Aichi
0561-63-1683
thimeno@aichi-med-u.ac.jp
Aichi Medical University
Division of Diabetes, Department of Internal Medicine, Aichi Medical University
Self funding
Aichi Medical University School of Medicine
1-1 Yazakokarimata, Nagakute, Aichi
0561-63-1683
thimeno@aichi-med-u.ac.jp
NO
2016 | Year | 04 | Month | 16 | Day |
Unpublished
Terminated
2016 | Year | 01 | Month | 20 | Day |
2016 | Year | 01 | Month | 20 | Day |
2016 | Year | 03 | Month | 01 | Day |
2023 | Year | 02 | Month | 28 | Day |
2016 | Year | 04 | Month | 15 | Day |
2021 | Year | 02 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024422
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |